课题基金 / 基金详情

The Efficacy of Adjunctive S-Adenosyl Methionine (SAMe) versus a Combination Nutraceutical in Clinical Depression: A Double-Blind, Randomised, Placebo-Controlled Trial

The Efficacy of Adjunctive S-Adenosyl Methionine (SAMe) versus a Combination Nutraceutical in Clinical Depression: A Double-Blind, Randomised, Placebo-Controlled Trial
辅助 S-腺苷甲硫氨酸 (SAMe) 与组合营养药物治疗临床抑郁症的疗效:双盲、随机、安慰剂对照试验
批准号:
nhmrc : 1048222
负责人:
Dr Chad Bousman
金额:
$53.36万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 2017-12-31

项目摘要

项目成果

Dr Chad Bousman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
An emerging approach to treat depression is via the use of adjunctive nutraceuticals (nutrient-based natural products). Specific antidepressant nutraceuticals can target a range of key neurological pathways that can treat depression. We are conducting an 8 week clinical trial comparing the efficacy of a range of nutraceuticals- such as folic acid, omega-3, and zinc, in adults with depression who are non-responsive to current pharmaceutical antidepressants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHARMACOGENETICS OF ANTIDEPRESSANT RESPONSE AND REMISSION: TOWARD GENOTYPE-GUIDED PRESCRIBING IN MAJOR DEPRESSIVE DISORDER
  • 批准号:
    nhmrc : 1127700
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $29.04万
  • 财政年份:
    2017
  • 负责人:
    Dr Chad Bousman
  • 依托单位:
Kava for the Treatment of Generalized Anxiety Disorder: A 16-Week Double-Blind RCT
  • 批准号:
    nhmrc : 1063383
  • 项目类别:
    Project Grants
  • 资助金额:
    $45.38万
  • 财政年份:
    2014
  • 负责人:
    Dr Chad Bousman
  • 依托单位:
海外基金